
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
From blowouts to big interiors, ‘Tuscan Mom’ style is Gen Z’s answer to beige burnout - 2
Swap The Amalfi Coast For This Low-Cost Ligurian Seaside Town - 3
Step by step instructions to Figure out the Natural Effect of 5G Pinnacles - 4
Why are NASA's Artemis astronauts wearing orange? What are they bringing to space? What to know about the preparation for their moon mission. - 5
Russia earning billions from Hormuz blockade, German trade body says
With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
Lily Allen 2026 'West End Girl' arena tour: How to get tickets, prices and more
Two die and thousands homeless after flooding hits Russia's Dagestan
Japanese H3 rocket fails during launch of navigation satellite (video)
Avoid Slam: Exploring the Pickup Truck Transformation
Vote in favor of your Number one natural product
6 Famous Cell phone Brands All over The Planet
Eight arrested in joint Scotland and Spain gang raids
Figure out How to Take part in Open Conversations Around 5G Pinnacles













